The postmenopausal woman with abnormal uterine bleeding is considered at risk for developing endometrial neoplasia or one of its precursors. She requires prompt evaluation of the endometrium followed by adequate treatment. In the subgroup of postmenopausal women taking hormone replacement therapy (HRT), the risk of abnormal bleeding is by far higher, is the main reason for discontinuing HRT, and deserves additional attention.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s1074-3804(05)60630-5 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!